SMAD3 and central nervous system cancer: Similarly, Kjellman et al analyzed the mRNA expression levels of Smad2 and Smad3 in tissue specimens from 23 cases of glioma, in which decreased mRNA levels of Smad2 and Smad3 were observed and correlated with the degree of malignancy (5).